Proprietary Client Program
A A A
| Drug |
Marketed analgesic |
| Goal |
Improve bioavailablity of a marketed pain drug |
| Challenges |
Improve onset-of-action and increase overall bioavailability, in comparison to the marketed reference |
| Solution |
Biorise® |
| Data |
Clinical studies show a clear increase in the rate at which therapeutic blood levels were achieved with the Biorise formulation and a marked increase in bioavailability. |
Chart : Comparison of plasma levels of drug for Biorise formulation (in red) versus the reference product (in green) in healthy human subjects (N=36).
| Result |
The Biorise formulation is clearly a superior pain-relief medication as it acts more rapidly. In addition, the formulation potentially allows a lower amount of drug to be used for an equivalent therapeutic effect, a valuable and differentiating feature. |
| Product Achieved |
Proprietary |
